GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis
OSL:GENT - Euronext Oslo - NO0010748866 - Common Stock - Currency: NOK
Overall GENT gets a fundamental rating of 6 out of 10. We evaluated GENT against 60 industry peers in the Health Care Equipment & Supplies industry. While GENT has a great health rating, its profitability is only average at the moment. GENT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
GENT had positive earnings in the past year.
In the past year GENT had a positive cash flow from operations.
In the past 5 years GENT reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
1.2 Ratios
GENT has a better Return On Assets (19.72%) than 94.55% of its industry peers.
The Return On Equity of GENT (23.34%) is better than 89.09% of its industry peers.
GENT has a Return On Invested Capital of 6.07%. This is in the better half of the industry: GENT outperforms 67.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 19.72% | ||
| ROE | 23.34% | ||
| ROIC | 6.07% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of GENT (29.78%) is better than 96.36% of its industry peers.
GENT has a Operating Margin of 10.34%. This is in the better half of the industry: GENT outperforms 65.45% of its industry peers.
With a Gross Margin value of 54.46%, GENT perfoms like the industry average, outperforming 47.27% of the companies in the same industry.
GENT's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.34% | ||
| PM (TTM) | 29.78% | ||
| GM | 54.46% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
2. Health
2.1 Basic Checks
GENT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GENT has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, GENT has about the same amount of shares outstanding.
GENT has a better debt/assets ratio than last year.
2.2 Solvency
GENT has an Altman-Z score of 12.99. This indicates that GENT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 12.99, GENT belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Debt to FCF ratio of GENT is 2.20, which is a good value as it means it would take GENT, 2.20 years of fcf income to pay off all of its debts.
GENT's Debt to FCF ratio of 2.20 is amongst the best of the industry. GENT outperforms 87.27% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that GENT is not too dependend on debt financing.
GENT's Debt to Equity ratio of 0.03 is amongst the best of the industry. GENT outperforms 92.73% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 2.2 | ||
| Altman-Z | 12.99 |
ROIC/WACC0.72
WACC8.47%
2.3 Liquidity
A Current Ratio of 5.38 indicates that GENT has no problem at all paying its short term obligations.
GENT has a Current ratio of 5.38. This is amongst the best in the industry. GENT outperforms 98.18% of its industry peers.
A Quick Ratio of 3.85 indicates that GENT has no problem at all paying its short term obligations.
GENT's Quick ratio of 3.85 is amongst the best of the industry. GENT outperforms 90.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.38 | ||
| Quick Ratio | 3.85 |
3. Growth
3.1 Past
GENT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 520.09%, which is quite impressive.
Looking at the last year, GENT shows a quite strong growth in Revenue. The Revenue has grown by 12.52% in the last year.
The Revenue has been growing by 25.96% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)520.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%420.06%
Revenue 1Y (TTM)12.52%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.73%
3.2 Future
Based on estimates for the next years, GENT will show a very strong growth in Earnings Per Share. The EPS will grow by 58.89% on average per year.
Based on estimates for the next years, GENT will show a very strong growth in Revenue. The Revenue will grow by 31.47% on average per year.
EPS Next Y76.24%
EPS Next 2Y58.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year33.11%
Revenue Next 2Y31.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 16.31, the valuation of GENT can be described as correct.
GENT's Price/Earnings ratio is rather cheap when compared to the industry. GENT is cheaper than 90.91% of the companies in the same industry.
GENT is valuated rather cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 25.78, GENT can be considered very expensive at the moment.
The rest of the industry has a similar Price/Forward Earnings ratio as GENT.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, GENT is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.31 | ||
| Fwd PE | 25.78 |
4.2 Price Multiples
GENT's Enterprise Value to EBITDA ratio is in line with the industry average.
GENT's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 287.86 | ||
| EV/EBITDA | 26.02 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GENT's earnings are expected to grow with 58.89% in the coming years.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y58.89%
EPS Next 3YN/A
5. Dividend
5.1 Amount
GENT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OSL:GENT (3/7/2025, 7:00:00 PM)
46.8
-0.8 (-1.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners30.99%
Inst Owner ChangeN/A
Ins Owners2.59%
Ins Owner ChangeN/A
Market Cap721.66M
Analysts85.71
Price Target68.34 (46.03%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)18.67%
EPS NY rev (3m)9.88%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-9.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.31 | ||
| Fwd PE | 25.78 | ||
| P/S | 4.75 | ||
| P/FCF | 287.86 | ||
| P/OCF | 53.63 | ||
| P/B | 3.72 | ||
| P/tB | 4.36 | ||
| EV/EBITDA | 26.02 |
EPS(TTM)2.87
EY6.13%
EPS(NY)1.82
Fwd EY3.88%
FCF(TTM)0.16
FCFY0.35%
OCF(TTM)0.87
OCFY1.86%
SpS9.86
BVpS12.58
TBVpS10.74
PEG (NY)0.21
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 19.72% | ||
| ROE | 23.34% | ||
| ROCE | 7.88% | ||
| ROIC | 6.07% | ||
| ROICexc | 10.54% | ||
| ROICexgc | 14.02% | ||
| OM | 10.34% | ||
| PM (TTM) | 29.78% | ||
| GM | 54.46% | ||
| FCFM | 1.65% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 2.2 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 122.17% | ||
| Cap/Sales | 7.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 54.51% | ||
| Profit Quality | 5.54% | ||
| Current Ratio | 5.38 | ||
| Quick Ratio | 3.85 | ||
| Altman-Z | 12.99 |
F-Score5
WACC8.47%
ROIC/WACC0.72
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)520.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%420.06%
EPS Next Y76.24%
EPS Next 2Y58.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.52%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.73%
Revenue Next Year33.11%
Revenue Next 2Y31.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y318.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year153.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-77.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.94%
OCF growth 3YN/A
OCF growth 5YN/A